首页> 外文OA文献 >Sphingosine-1-Phosphate and Interleukin-1 Independently Regulate Plasminogen Activator Inhibitor-1 and Urokinase-Type Plasminogen Activator Receptor Expression in Glioblastoma Cells: Implications for Invasiveness

【2h】

Sphingosine-1-Phosphate and Interleukin-1 Independently Regulate Plasminogen Activator Inhibitor-1 and Urokinase-Type Plasminogen Activator Receptor Expression in Glioblastoma Cells: Implications for Invasiveness

机译：鞘氨醇-1-磷酸酯和白细胞介素-1独立地调节纤维素激活剂抑制剂-1和尿激酶型纤溶酶原激活剂对胶质母细胞瘤细胞中的表达：对侵袭性的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lauren Bryan; Barbara S. Paugh; Dmitri Kapitonov; Katarzyna M. Wilczynska; Silvina M. Alvarez; Sandeep K. Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. [J] . Bryan L, Paugh BS, Kapitonov D, Molecular cancer research: MCR . 2008,第9期

机译：鞘氨醇-1-磷酸和白介素-1独立调节胶质母细胞瘤细胞中的纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物受体的表达：对侵袭性的影响。
2. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and -2 in hepatocellular carcinoma. [J] . Zhou L, Hayashi Y, Itoh T, Pathology International . 2000,第5期

机译：尿激酶型纤溶酶原激活物，尿激酶型纤溶酶原激活物受体和纤溶酶原激活物抑制剂-1和-2在肝细胞癌中的表达。
3. Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. [J] . Qin W, Zhu W, Wagner Mann C, Annals of surgical oncology . 2003,第8期

机译：尿激酶型纤溶酶原激活物，纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物受体的乳头抽吸液表达可预测乳腺癌的诊断和晚期疾病。
4. Inhibition of the Tumor-Associated Urokinase-Type Plasminogen Activation System: Effects of High-Level Synthesis of Soluble Urokinase Receptor in Ovarian and Breast Cancer Cells In Vitro and In Vivo [C] . Viktor Magdolen International Meeting on Molecular Staging on Cancer . 2003

机译：抑制肿瘤相关的尿激酶型纤溶酶原激活系统：高水平合成在体外和体内卵巢癌细胞中可溶性尿激酶受体的影响
5. Estrogen receptor beta: Influence on urokinase-type plasminogen activator in vascular smooth muscle cells. [D] . Paradis, Madeleine Aimee. 2003

机译：雌激素受体β：对血管平滑肌细胞中尿激酶型纤溶酶原激活剂的影响。
6. Sphingosine-1-Phosphate Regulates Glioblastoma Cell Invasiveness Through The Urokinase Plasminogen Activator System and CCN1/Cyr61 [O] . Nicholas Young, Dennis K. Pearl, James R. Van Brocklyn -1

机译：1磷酸鞘氨醇通过尿激酶纤溶酶原激活物系统和CCN1 / Cyr61调节胶质母细胞瘤细胞侵袭
7. Expression of Urokinase-type Plasminogen Activator (uPA), uPA Receptor, and Plasminogen Activator Inhibitor-1 in Oral Squamous Cell Carcinoma [O] . Inoue Yoshiko, Sugiura Tsuyoshi, Matsuki Ryousuke, 2007

机译：尿激酶型纤溶酶原激活物（uPA），uPA受体和纤溶酶原激活物抑制剂1在口腔鳞状细胞癌中的表达

Sphingosine-1-Phosphate and Interleukin-1 Independently Regulate Plasminogen Activator Inhibitor-1 and Urokinase-Type Plasminogen Activator Receptor Expression in Glioblastoma Cells: Implications for Invasiveness

著录项

引文网络

相似文献

相关主题

期刊订阅